Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2023 Oct 17;11(10):e7896. doi: 10.1002/ccr3.7896

First reported Rhodotorula mucilaginosa brain abscess: Found as coinfection in woman with common variable immune deficiency

Arjun Bhatt 1,, Melinda S Dunlap 2, Han Pham 3, Kimmo J Hatanpaa 3, Philip Boyer 3, Rita M Gander 3, Anna G Symmes 1,
PMCID: PMC10582238  PMID: 37860048

Key Clinical Message

Rhodotorula is a rare pathogen seen in the immunocompromised host; while cases of Rhodotorula meningitis have been reported, there are no published cases of Rhodotorula brain abscess. We describe the diagnosis and management of a woman with common variable immune deficiency presenting with concomitant Rhodotorula and Nocardia brain abscesses.

Keywords: brain abscess, CVID, nocardia, rhodotorula


In a patient with newly diagnosed common variable immunodeficiency and clinical symptoms, brain MRI demonstrated intra‐axial ring‐enhancing lesions with restricted diffusion and surrounding edema. These lesions were revealed to be Nocardia and Rhodotorula brain abscesses.

graphic file with name CCR3-11-e7896-g002.jpg

1. INTRODUCTION

Rhodotorula, a pink to red‐pigmented yeast in the family Sporidiobolaceae, is considered a ubiquitous commensal organism. Previously, Rhodotorula was not considered a human pathogen, but with the increasing prevalence of infectious niduses (e.g., central venous catheters), Rhodotorula has since emerged as a cause of opportunistic infection with a prevalence between 0.5% and 2.3% among patients with fungemia. 1 , 2 Limited data suggests the disease mostly spreads from an infectious source to its destination through central vasculature; peripheral cultures may be falsely negative. 3 Previous reports of Rhodotorula infections have included sepsis, pneumonia, meningitis and endocarditis, typically in immunocompromised hosts. 3 , 4 To our knowledge, no case of Rhodotorula brain abscess in either an immunocompetent or immunocompromised host has yet been reported. 1 , 5 , 6 , 7 Here, we describe a case of a 40‐year‐old Caucasian woman with common variable immune deficiency (CVID) and brain abscesses due to both Rhodotorula mucilaginosa and Nocardia abscessus.

2. CASE HISTORY AND EXAMINATION

A 40‐year‐old Caucasian woman presented to the emergency department complaining of fevers, worsening shortness of breath, and new‐onset witnessed tonic–clonic seizures. Her medical history was significant for mental retardation, tobacco usage of 40 pack years, chronic obstructive pulmonary disease diagnosed in her 30s with a 2 L O2 home oxygen requirement, and multiple complicated previous hospitalizations for various infections. She also endorsed 2 months of unwitnessed syncopal episodes, headaches with intense pain over the left eye, worsening dyspnea with exertion (able to walk 15 feet from a baseline of 100), cough producing yellow sputum, and weight loss. She had no associated photophobia, neck rigidity, or blurred vision. On physical exam, she was febrile to 103°F, tachycardic, and hypoxemic despite home oxygen support. She had diffuse crackles throughout both lung fields; subsequent chest x‐ray showed expanded lung fields consistent with the patient's known COPD, and a diffuse reticulonodular infiltrate suggested by CT scan to be necrotizing pneumonia with cavitation. Brain MRI revealed multiple scattered intra‐axial ring‐enhancing lesions in the left posterior frontal lobe, left posterior parietal lobe, right occipital lobe and left temporal lobe, all with restricted diffusion, and surrounding edema (Figure 1).

FIGURE 1.

FIGURE 1

Brain MRI demonstrated intra‐axial ring‐enhancing lesions in the left posterior frontal lobe, left posterior parietal lobe, right occipital lobe and left temporal lobe, all with restricted diffusion and surrounding edema.

3. DIFFERENTIAL DIAGNOSIS, INVESTIGATIONS, AND TREATMENT

Given these findings, empiric antibiotic treatment was started for suspected brain abscess, but as metastatic disease could not be ruled out, brain, and transbronchial biopsies were performed. Histopathologic examination revealed a brain abscess with both budding yeast and filamentous bacilli (Figure 2), and cultures of the brain biopsy grew R. mucilaginosa and N. abscessus. Lung biopsy was unremarkable. Due to the rare, invasive fungal infection in the absence of known risk factors such as CVC, workup for immunocompromising conditions was undertaken, aspects of which are presented in Table 1. This workup eventually revealed a diagnosis of CVID. Empiric antibiotic therapy was thus replaced with meropenem, trimethoprim‐sulfamethoxazole, and liposomal amphotericin B. Amphotericin B associated electrolyte abnormalities prompted a switch to voriconazole, but unfortunately, despite several weeks of intensive medical therapy, the patient's respiratory status continued to decline, and she was transferred to the ICU for mechanical ventilation.

FIGURE 2.

FIGURE 2

Histologic evaluation of brain tissue identified: (A) abundant necrotic debris and a chronic inflammatory cell infiltrate admixed with fungal forms (thin arrow) and filamentous bacteria (thick arrows) within the parenchyma (Gomori's methenamine silver (GMS) stain; 400 x magnification); (B) On higher magnification, hyphal forms with globose yeast cells (Periodic acid‐Schiff stain; 1000 x oil magnification) and (C) beaded, branching filamentous bacteria were seen (GMS; 1000 x oil magnification).

TABLE 1.

The diagnostic workup leading to a diagnosis of CVID included multiple HIV tests, which were consistently negative, titers that remained low despite vaccinations, a positive mitogen induced lymphocyte blastogenesis test, and negative purine nucleoside phosphorylase and adenosine deaminase tests. Based on the patient's hypogammaglobulinemia, impaired antibody response, negative HIV test, and mitogen tests, the patient was believed to have common variable immune deficiency.

Lab Result
HIV

PCR

p24

viral load

CD4

Negative

Negative

0

47–198

Immunodeficiency

CD3

CD8

88

88

Immunization titers

Pneumococcal

Diphtheria

Tetanus

Undetectable

0.01

0.16

Immunoglobulins

IgG

IgA

IgM

IgE

155 (nl > 400)

20

36

< 2

Mitogen induced lymphocyte blastogenesis

Purine nucleoside phosphorylase assay

Adenosine deaminase test

Markedly reduced

Negative

Negative

4. OUTCOME AND FOLLOW‐UP

After 2 weeks, the patient was still dependent upon mechanical ventilation and prognosis was felt to be poor. Tracheostomy was discussed with the patient's power of attorney, but after continued deterioration, comfort measures were prioritized, and the patient passed.

5. DISCUSSION

Rhodotorula remains a rare cause of infection. Previous reports of disease caused by Rhodotorula have primarily been found in immunocompromised hosts— such as the patient presented here with CVID— with a majority of these involving CVC—associated infections. 8 , 9 , 10 , 11 As it is still not clear why some immunocompromised patients develop complications such as Rhodotorula meningitis or endocarditis whereas others simply have fungemia, patient history, and clinical presentation alone may not converge on Rhodotorula. 12 , 13 Thus, histopathologic evaluation remains essential to confirming diagnosis and, as in this case, determining treatment course. There remains no definitive treatment algorithm for Rhodotorula: suggested treatments include simple supportive care, fluconazole, various formulations and dosing regimens of amphotericin B with or without flucytosine, and flucytosine/itraconazole combinations. 14 , 15 As seen in our patient, these regimens often cause complications due to their toxicities. Additionally, this patient's comorbidities, especially her coexisting respiratory failure, were felt to have contributed to her poor outcome. We hope the contribution of this novel manifestation of Rhodotorula as causing brain abscesses nonetheless serves as another datapoint to hopefully improving the diagnosis and management of this rare disease.

AUTHOR CONTRIBUTIONS

Arjun Bhatt: Investigation; project administration; writing – original draft; writing – review and editing. Melinda S. Dunalp: Conceptualization; investigation; methodology; writing – review and editing. Han Pham: Conceptualization; investigation; methodology; resources. Kimmo J. Hatanpaa: Conceptualization; data curation; investigation; methodology; supervision; writing – review and editing. Philipp Boyer: Project administration. Rita M. Gander: Investigation; methodology. Anna G. Symmes: Supervision; writing – review and editing.

FUNDING INFORMATION

The author(s) received no financial support for the research, authorship, and/or publication of this article.

CONFLICT OF INTEREST STATEMENT

All authors declare that they have no conflicts of interest.

CONSENT

Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.

ACKNOWLEDGMENTS

We thank Deanna A. Sutton, Ph.D for reviewing the stained slides, Sanjay Revankar, M.D. for reviewing the manuscript and Bobbie Wortham for administrative assistance in manuscript preparation.

Bhatt A, Dunlap MS, Pham H, et al. First reported Rhodotorula mucilaginosa brain abscess: Found as coinfection in woman with common variable immune deficiency. Clin Case Rep. 2023;11:e7896. doi: 10.1002/ccr3.7896

Contributor Information

Arjun Bhatt, Email: bhatta16@students.ecu.edu.

Anna G. Symmes, Email: symmesa21@ecu.edu.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1. Kiehn TE, Goryey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis. 1992;14:841‐846. [DOI] [PubMed] [Google Scholar]
  • 2. Wirth F, Goldani LZ. Epidemiology of Rhodotorula: an emerging pathogen. Interdiscip Perspect Infect Dis. 2012;2012:465717. doi: 10.1155/2012/465717 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Riopedre RN, De Cesare I, Miatello E, Caria MA, Zapater RC. Isolation of Rhodotorula mucilaginosa from CSF, feces, urine, pharyngeal and skin of a 3‐month‐old infant. Rev Asoc Med Argent. 1960;74:431‐434. [PubMed] [Google Scholar]
  • 4. Kim H, Byeon SJ, Kim CH, Bae YA, Lee H, Kim HS. A case of localized fungal pneumonia caused by Rhodotorula mucilaginosa in an immunocompetent patient. Ann Lab Med. 2021. Jan;41(1):120‐122. doi: 10.3343/alm.2021.41.1.120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Huttova M, Kralinsky K, Horn J, et al. Prospective study of nosocomial fungal meningitis in children‐report of 10 cases. Scand J Infect Dis. 1998;30:485‐487. [DOI] [PubMed] [Google Scholar]
  • 6. Pore RS, Chen J. Meningitis caused by Rhodotorula . Sabouraudia. 1976;14:331‐335. [PubMed] [Google Scholar]
  • 7. Maeder M, Vogt PR, Schaer G, von Graevenitz A, Gunthard HF. Aortic homograft endocarditis caused by Rhodotorula mucilaginosa . Infection. 2003;31:181‐183. [DOI] [PubMed] [Google Scholar]
  • 8. Ahmed A, Aggarwal M, Chiu R, Ramratnam B, Rinaldi M, Flanigan TP. A fatal case of Rhodotorula meningitis in AIDS. Med Health R. 1998;I(81):22‐23. [PubMed] [Google Scholar]
  • 9. Gyaurgieva OH, Bogomolovva TS, Gorshkova GI. Meningitis caused by Rhodotorula rubra in an HIV‐infected patient. J Med Vet Mycol. 1996;34:357‐359. [PubMed] [Google Scholar]
  • 10. Lui AY, Turett GS, Karter DL, Bellman PC, Kislak JW. Amphotericin B lipid complex therapy in an AIDS patient with Rhodotorula rubra fungemia. Clin Infect Dis. 1998;27:892‐893. [DOI] [PubMed] [Google Scholar]
  • 11. Braun DK, Kaufmann CA. Rhodotorula fungaemia: a life‐threatening complication of indwelling central venous catheters. Mycoses. 1992;35:305‐308. [DOI] [PubMed] [Google Scholar]
  • 12. Chung JW, Kim BN, Kim YS. Central venous catheter‐related Rhodotorula rubra fungemia. J Infect Chemother. 2002;8:109‐110. [DOI] [PubMed] [Google Scholar]
  • 13. Petrocheilou‐Paschou V, Prifti H, Kostis E, Papadimitriou C, Dimoupoulos MA, Stamatelopoulos S. Rhodotorula septicemia: case report and minireview. Clin Microbiol Infect. 2001;7:100‐102. [DOI] [PubMed] [Google Scholar]
  • 14. Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol. 2003;41:5233‐5235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol. 2005;43:476‐478. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES